M-Vizion™ Macroscopic Radiographic Study
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Medacta USA
- Study ID
- NCT05721859
- Status
- Recruiting
Conditions
- Revision Hip Arthroplasty
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- revision hip arthroplasty — DEVICErevision hip arthroplasty
Study Details
Study of the patient's subsidence after revision hip arthroplasty by assessing gross stem subsidence in the femoral canal.
Key Dates
- Start date
- Oct 12, 2022
- Status verified
- May 2025
- Primary completion
- Jun 1, 2026
- Completion
- Jun 1, 2026
Study Design
- Enrollment
- 70 participants (estimated)
Primary Outcome Measure
subsidence [ Time Frame: 6 weeks post-op visit (± 2 weeks) ]
Central Contacts
- Emily Hord, CCRP331-208-4284
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Northwestern Medicine | Chicago | Illinois | 60611 | Melissa Shauver Megan VanDyke Kevin Hardt, MD (PRINCIPAL_INVESTIGATOR) |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | Michael Baratz, MD (PRINCIPAL_INVESTIGATOR) |
| New England Baptist Hospital | Boston | Massachusetts | 02120 | Eric Smith, MD (PRINCIPAL_INVESTIGATOR) |
| Dartmouth Health | Lebanon | New Hampshire | 03756 | Holly Symonds Wayne Moschetti, MD (PRINCIPAL_INVESTIGATOR) |
| OrthoCarolina Research Institute, Inc. | Charlotte | North Carolina | 28207 | Alexis Ready Caleb Michalek Bradley Ellison, MD (PRINCIPAL_INVESTIGATOR) |
| Geisinger Medical Center | Danville | Pennsylvania | 17822 | John Mercuri, MD (PRINCIPAL_INVESTIGATOR) |
| University of Utah Department of Orthopaedics | Salt Lake City | Utah | 84108 | Claire Kepron 801-213-7154 Lucas Anderson, MD (PRINCIPAL_INVESTIGATOR) Jeremy Gililland, MD (PRINCIPAL_INVESTIGATOR) |